about
Biogen is an established biopharmaceutical company focused on treatments for neurological diseases and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 45% of total revenue in 2024. Biogen als...
Read More
171.43
-2.37
(-1.36%)
558.6K
XNAS Volume
XNAS 23 Jan, 2026 3:15 PM (EST)
High Financial Strength
Affordable Valuation
Technically Neutral
Strong Performer, Under Radar
These stocks have good quality scores and strong financials. They are affordably priced stocks with potential for good returns
View Similar
Embed DVM
Biogen Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..